Sheaff Brock Investment Advisors LLC Purchases 10,963 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sheaff Brock Investment Advisors LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 235.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,620 shares of the company’s stock after acquiring an additional 10,963 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,420,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in GEHC. Turtle Creek Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at about $30,000. BNP Paribas purchased a new stake in GE HealthCare Technologies during the first quarter valued at about $30,000. Sachetta LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at about $31,000. Rise Advisors LLC boosted its position in GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after buying an additional 239 shares during the period. Finally, Riverview Trust Co purchased a new stake in GE HealthCare Technologies during the first quarter valued at about $31,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several analyst reports. Citigroup upped their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Mizuho dropped their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Argus increased their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Evercore ISI increased their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Finally, Bank of America dropped their target price on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $94.09.

GE HealthCare Technologies Trading Up 0.7 %

GEHC stock traded up $0.58 during trading on Friday, reaching $80.50. The company had a trading volume of 2,531,995 shares, compared to its average volume of 3,089,492. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The company has a market cap of $36.75 billion, a P/E ratio of 23.54, a PEG ratio of 2.87 and a beta of 1.20. The business has a 50 day moving average of $78.65 and a 200 day moving average of $82.14. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same period in the prior year, the firm earned $0.85 earnings per share. GE HealthCare Technologies’s revenue was down 1.2% on a year-over-year basis. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is 3.51%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez bought 1,315 shares of the firm’s stock in a transaction on Wednesday, May 1st. The stock was acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the purchase, the insider now owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CEO Jan Makela sold 66,955 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the completion of the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at $5,165,395.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, with a total value of $100,623.80. Following the transaction, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 90,482 shares of company stock valued at $7,369,137. Corporate insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.